Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing.
Most RNA viruses lack the mechanisms to recognize and correct mutations that arise during genome replication, resulting in quasispecies diversity that is required for pathogenesis and adaptation. However, it is not known how viruses encoding large viral RNA genomes such as the Coronaviridae (26 to 32 kb) balance the requirements for genome stability and quasispecies diversity. Further, the limits of replication infidelity during replication of large RNA genomes and how decreased fidelity impacts virus fitness over time are not known. Our previous work demonstrated that genetic inactivation of the coronavirus exoribonuclease (ExoN) in nonstructural protein 14 (nsp14) of murine hepatitis virus results in a 15-fold decrease in replication fidelity. However, it is not known whether nsp14-ExoN is required for replication fidelity of all coronaviruses, nor the impact of decreased fidelity on genome diversity and fitness during replication and passage. We report here the engineering and recovery of nsp14-ExoN mutant viruses of severe acute respiratory syndrome coronavirus (SARS-CoV) that have stable growth defects and demonstrate a 21-fold increase in mutation frequency during replication in culture. Analysis of complete genome sequences from SARS-ExoN mutant viral clones revealed unique mutation sets in every genome examined from the same round of replication and a total of 100 unique mutations across the genome. Using novel bioinformatic tools and deep sequencing across the full-length genome following 10 population passages in vitro, we demonstrate retention of ExoN mutations and continued increased diversity and mutational load compared to wild-type SARS-CoV. The results define a novel genetic and bioinformatics model for introduction and identification of multi-allelic mutations in replication competent viruses that will be powerful tools for testing the effects of decreased fidelity and increased quasispecies diversity on viral replication, pathogenesis, and evolution.
Eckerle
Lance D
LD
Department of Pediatrics and Microbiology and Immunology and Elizabeth B. Lamb Center for Pediatric Research, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Becker
Michelle M
MM
Halpin
Rebecca A
RA
Li
Kelvin
K
Venter
Eli
E
Lu
Xiaotao
X
Scherbakova
Sana
S
Graham
Rachel L
RL
Baric
Ralph S
RS
Stockwell
Timothy B
TB
Spiro
David J
DJ
Denison
Mark R
MR
D000595:Amino Acid Sequence; D000818:Animals; D002522:Chlorocebus aethiops; D019143:Evolution, Molecular; D005095:Exoribonucleases / Q000235:genetics*; D005818:Genetic Engineering; D014644:Genetic Variation; D016679:Genome, Viral; D008957:Models, Genetic; D008969:Molecular Sequence Data; D009154:Mutation; D010641:Phenotype; D020641:Polymorphism, Single Nucleotide; D045473:Severe acute respiratory syndrome-related coronavirus / Q000201:enzymology / Q000235:genetics / Q000254:growth & development; D045169:Severe Acute Respiratory Syndrome / Q000821:virology*; D014709:Vero Cells; D017361:Viral Nonstructural Proteins / Q000235:genetics*; D014779:Virus Replication / Q000235:genetics
D017361:Viral Nonstructural Proteins; C525596:nsp14 protein, SARS coronavirus; D005095:Exoribonucleases
J Mol Biol. 2003 Aug 29;331(5):991-1004
12927536
Biochemistry. 2003 Sep 9;42(35):10462-71
12950173
PLoS Biol. 2008 Sep 16;6(9):e226
18798692
J Gen Virol. 2001 May;82(Pt 5):1049-1060
11297679
Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):13910-3
10570172
Virology. 2007 Apr 10;360(2):469-76
17134731
Nature. 2008 Nov 6;456(7218):53-9
18987734
J Viral Hepat. 2003 Nov;10(6):413-22
14633173
Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7160-4
1831267
Curr Top Microbiol Immunol. 2005;287:31-55
15609508
PLoS Pathog. 2008 May 02;4(5):e1000054
18451981
J Biochem Mol Biol. 2007 Sep 30;40(5):649-55
17927896
J Virol. 2005 Dec;79(23):14909-22
16282490
PLoS Pathog. 2005 Oct;1(2):e11
16220146
Adv Exp Med Biol. 1995;380:499-506
8830530
J Virol. 1990 Aug;64(8):3960-2
1695258
Genetics. 2009 Oct;183(2):747-9
19652180
PLoS Comput Biol. 2005 Nov;1(6):e61
16322763
J Virol. 2004 Jan;78(2):980-94
14694129
J Virol. 2003 Oct;77(19):10515-27
12970436
Nucleic Acids Res. 1997 Dec 15;25(24):5110-8
9396823
Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7289-94
12754380
Genome Res. 2009 Sep;19(9):1646-54
19592482
PLoS One. 2009 May 25;4(5):e5683
19479085
Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2542-7
14983045
Science. 2004 Mar 12;303(5664):1666-9
14752165
J Virol. 1991 Jun;65(6):2960-7
2033662
Genome Res. 2007 Aug;17(8):1195-201
17600086
Cell. 1978 Apr;13(4):735-44
657273
Nature. 2006 Jan 19;439(7074):344-8
16327776
Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19944-9
19036930
J Virol. 2007 Nov;81(22):12135-44
17804504
Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):5108-13
16549795
Adv Exp Med Biol. 2006;581:535-8
17037593
EMBO J. 2006 Oct 18;25(20):4933-42
17024178
Nat Med. 2008 Feb;14(2):154-61
18246077
Biotechniques. 2009 Mar;46(3):229-31
19317667
J Bacteriol. 2008 Oct;190(19):6290-301
18676670
Virus Res. 2006 Apr;117(1):17-37
16503362
PLoS Pathog. 2009 Nov;5(11):e1000658
19911056
Virus Res. 2005 Feb;107(2):173-81
15649563
Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12995-3000
14569023
Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12546-51
16891412
PLoS Pathog. 2007 Jan;3(1):e5
17222058
Nat Med. 2000 Dec;6(12):1375-9
11100123
J Virol. 2007 Mar;81(6):2930-9
17202214
Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3484-9
19208801
J Virol. 2007 Nov;81(21):11722-9
17699579
J Biol Chem. 2005 Jul 8;280(27):25706-16
15878882
J Virol. 2004 Nov;78(22):12218-24
15507608
Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6895-900
11371613
J Virol. 2004 Sep;78(18):9837-41
15331718
J Gen Virol. 2006 Nov;87(Pt 11):3349-3353
17030869
J Virol. 2006 Nov;80(21):10900-6
16928748
BMC Bioinformatics. 2008 Apr 11;9:191
18405373
PLoS One. 2007 May 23;2(5):e459
17520018
J Med Virol. 2005 Aug;76(4):435-40
15977248
Bioinformatics. 2010 Jan 1;26(1):127-9
19880367
Proc Natl Acad Sci U S A. 1988 Sep;85(18):6811-5
2842792
J Virol. 2005 Nov;79(21):13399-411
16227261